Allogene Therapeutics (ALLO) EBITDA Margin Growth (1y) (2022 - 2024)
Allogene Therapeutics (ALLO) EBITDA Margin Growth (1y) (2022 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 1,049.00 |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 1,997.00 |
| 10 | Allogene Therapeutics | 427.72 Mn | 427.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | -3.45 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | -24.64 Mn |
| Mar 31, 2023 | -12.51 Mn |
| Dec 31, 2022 | -37.08 Mn |
| Sep 30, 2022 | -14.71 Mn |
| Jun 30, 2022 | 4.17 Mn |
| Mar 31, 2022 | -20.51 Mn |